DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
Clinical trial NCT00003840 · COMPLETED
Trial details
- NCT number
- NCT00003840
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
- Primary completion
- 2002-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.